Articles Tagged With: HPV
-
HPV Vaccination Rate Needs Improvement
The prevalence of HPV infections and their sequelae remain high, although this is a problem that is preventable with available vaccines.
-
HPV Vaccination in Adolescence Prevents Cancer More than 10 Years Later
In a study of human papillomavirus (HPV) vaccination, researchers evaluated cancer protection over up to 11 years of follow-up. During this time, the authors noted 100% vaccine efficacy at preventing HPV-associated cancers.
-
Human Papillomavirus Infections: We Need to Improve Vaccination Rates
The prevalence of human papillomavirus infections and their sequelae remain high, although this is a problem that is preventable with available vaccines.
-
HPV Vaccination in Adolescence Prevents Cancer More than 10 Years Later
This long-term follow-up study of three cluster-randomized trials of human papillomavirus (HPV) vaccination evaluated cancer protection over up to 11 years of follow-up. During this time, 17 HPV-positive cancers were identified in the unvaccinated group, and 0 were identified in the vaccinated group, indicating 100% vaccine efficacy at preventing HPV-associated cancers.
-
Providers Can Improve Condom Messaging to Patients
Reproductive health providers could help patients better understand their risks of both pregnancy and sexually transmitted infections (STIs) by asking nonjudgmental questions about their sexual activity, and offering testing for STIs and a vaccine for HPV. -
Better Education on Sexually Transmitted Infections Is Needed
A small study of women who responded to a study recruitment flier that offered a free, rapid HIV test revealed the participants knew very little about sexually transmitted infections. -
Do Women 64 to 66 Years of Age Qualify to Discontinue Cervical Screening?
These studies evaluated adherence to national guidelines for exiting from cervical cancer screening at 65 years of age and managing abnormal results on screening with human papillomavirus (HPV) and Pap co-testing and found that the majority of women 64 to 66 years of age do not qualify to discontinue screening, and the majority of women with discordant Pap and HPV test results are managed incorrectly.
-
Evaluation of an Inpatient Postpartum Human Papillomavirus Immunization Program
In this cohort study, results from two years of an inpatient postpartum HPV vaccination program are presented. Overall, their results show an increased rate of immunization (hazard ratio of 2.51) and an increased proportion of women completing the vaccination series (35.8% of those receiving an inpatient dose completed the series compared to 9.3% of those who did not get the inpatient dose).
-
The Cost-Effectiveness of HPV Vaccination for Adults Age 30 to 45 Years
Researchers found extending the upper limit of HPV vaccination to age 30 to 45 years is not cost-effective. -
New Guidelines Reinforce Need for Change in Cervical Cancer Screening Practice
Screening standards for cervical cancer have changed over the past two decades, including several updates since the first consensus guidelines, published in 2001 by the American Society of Colposcopy and Cervical Pathology. The 2020 revision is based on data showing that patients’ risk of developing cervical precancer or cancer can be estimated using screening test results, biopsy results, and consideration of personal patient factors.